Global Hypodermic Needles Market Size by Product, Application, End User, and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2032
Overview
Hypodermic Needles Market is expected to reach US$ 4.56 Bn. by 2032 from US$ 2.94 Bn. in 2025, at a CAGR of 6.5% during forecast period.
Hypodermic Needles Market Overview:
A hypodermic needle is a hollow needle that is widely used with a syringe to administer or remove fluids from the body. It is used to administer liquids quickly or when the injected drug cannot be consumed, either because it will not be absorbed (as with insulin) or because it will damage the liver.
To know about the Research Methodology :- Request Free Sample Report
Global Hypodermic Needles Market Dynamics:
Increasing demand for injectable drugs is the major factor driving the market growth.
One of the main growth-driving factors for global hypodermic needles is the growing geriatric population and demand for vaccines. The rising prevalence of various chronic diseases, as well as the growing number of hospitals and clinics in developing countries, are expected to boost the market's growth over the forecast period. Increasing cases of chronic diseases such as cancer, cardiovascular disorders and others worldwide prove to be the primary growth driving factor.
Prevalence of chronic diseases can be due to sedentary lifestyles, obesity, poor eating patterns, and high tobacco and alcohol intake. According to the American Heart Association's 2019 study, cardiovascular disease (CVD) is the leading global cause of death, with more than 17.6 million deaths a year in 2016, and more than 23.6 million by 2030. Diabetes is predicted to become more prevalent in the future. Injection and infusion procedures are being used more often as a result of successful government programmes.
The number of people living with diabetes is projected to rise from 463 million in 2019 to nearly 578.4 million in 2030, according to the International Diabetes Federation's 2019 report. Rising demand to avoid needle-prick accidents boosts the market growth for hypodermic needles. The demand for hypodermic needles is expected to grow due to a significant increase in injection-based therapies and therapeutic systems.
Manufacturers of hypodermic needles are incorporating a variety of user-friendly features into their goods, such as the absence of recapping to minimise infection exposure, shorter needles, and fine gauge needles for less discomfort. Hypodermic needles are expected to become more common as a result of these user-friendly features.
Alternative ways of drug delivery and high costs associated with the protection of hypodermic needles, on the other hand, limit the market growth. This market's growth is expected to get hampered by the high risk of infection associated with drug delivery through hypodermic needles. Lack of awareness about these needles in various developing regions of the world is also expected to hinder the market growth.
The report has profiled twenty-two key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Global Hypodermic Needles Market Segment Analysis:
The Global Hypodermic Needles Market is segmented on the basis of Product, Application and End-Users.
Based on Product, the safety hypodermic needles segment held a significant share in 2020. This segment is expected to grow at a faster rate during the forecast period. Safety needles are becoming more common due to their built-in safety mechanisms, and technical advances and innovation in the production of multi-safety needles are some of the factors driving this segment's growth.
Another factor contributing to the growth is the reduced risk of needle stick injuries, which can result in the transmission of blood-borne pathogens including HIV and the hepatitis B and C viruses. Safety needles minimise the risk of infection, cost-effective, and are more convenient for practical use.
Based on Application, the Drug delivery segment is the dominant segment. It is expected to continue the dominance throughout the forecast period. Hypodermic Needles are often used in drug delivery to infuse the intended drug (therapeutic) into the patient's body since they help the body absorb the drug more quickly. The hypodermic needle is inserted into the dermis, which contains pain receptors. The stratum corneum barrier is bypassed, and the drug is delivered directly into the epidermis or upper dermis layer, delivering 100% of the loaded drug without discomfort.
Recent Development: Global Hypodermic Needles Market
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 14 January 2025 | Becton, Dickinson and Company (BD) | Launched the BD Effivax™ Glass Antigen Shield, a specialized safety-engineered needle system designed for high-viscosity biologic drug delivery. | This development enhances injection reliability and patient comfort by reducing the force-to-inject by 30% for complex chronic disease therapies. |
| 11 February 2025 | Terumo Corporation | Opened a new $150 million manufacturing facility in Asia specifically dedicated to producing taper-point hypodermic needles for global distribution. | The expansion scales up global supply chain resilience, targeting an annual production capacity increase of 2 billion units to meet rising immunization demands. |
| 07 May 2025 | Schott Pharma | Introduced an integrated needle-safety system for pre-fillable syringes utilizing ultra-thin wall technology to minimize patient trauma. | This innovation improves flow rates for medications while ensuring safety-lock mechanisms prevent accidental needlestick injuries in clinical settings. |
| 22 September 2025 | Gerresheimer AG | Partnered with a leading biotech firm to commercialize siliconized hypodermic needles that feature a low-friction coating for painless self-administration. | The collaboration accelerates the shift toward home-care healthcare models, enhancing patient compliance for daily injectable treatments. |
| 15 January 2026 | Nipro Corporation | Achieved EU MDR certification for its latest range of safety hypodermic needles featuring a single-handed activation shield. | Obtaining this regulatory approval allows for uninterrupted market access across Europe and reinforces workplace safety standards for healthcare professionals. |
| 04 March 2026 | Cardinal Health | Announced a strategic investment into sustainable needle designs that utilize recycled medical-grade polymers for outer safety casings. | This initiative aims to reduce plastic waste in hospitals by 15% without compromising the sterile integrity of the needle delivery system. |
Global Hypodermic Needles Market Regional Insights:
North America is expected to lead the global market during the forecast period.
In the forecast years, the market in this area is expected to grow at a rapid pace. The demand for hypodermic needles in the area is being driven by the rising prevalence of chronic and lifestyle-related diseases, as well as a growing focus on the use of safe injection technologies. The government’s introduction of favourable regulations is also benefiting the regional hypodermic needle market. Every year, approximately 647,000 Americans die from heart disease, accounting for nearly one-fourth of all deaths in the nation. Needles and syringes are needed for CVD treatment and therapy. As a consequence, the disease's high prevalence is expected to aid business development.
The report also helps in understanding Global Hypodermic Needles Market dynamics, structure by analyzing the market segments and project the Global Hypodermic Needles Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Hypodermic Needles Market make the report investor’s guide.
Global Hypodermic Needles Market Key Developments:
Boston, Massachusetts, USA, declared in April 2019 that they had coordinated a "Needle Take Back Day" in collaboration with a variety of health centres across the region. From 10 a.m. to 5 p.m., the citywide campaign will collect discarded needles, assisting with the problem of proper needle disposal. The city has stated that they would hold a public awareness campaign about the use of needles and how they should be treated.
Global Hypodermic Needles Market Scope: Inquire before buying
| Hypodermic Needles Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 2.94 USD Billion |
| Forecast Period 2026-2032 CAGR: | 6.5% | Market Size in 2032: | 4.56 USD Billion |
| Segments Covered: | by Product | Safety Hypodermic Needles Non-Safety Hypodermic Needles |
|
| by Application | Drug Delivery Vaccination Blood Specimen Collection Others |
||
| by End-Users | Hospitals Diabetic Patients Family Practices Psychiatrics Others |
||
| by Distribution Channel | Offline Online |
||
Global Hypodermic Needles Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Global Hypodermic Needles Market, Key Players are
- Becton Dickinson and Company (BD)
- Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Cardinal Health Inc.
- Medtronic plc
- Smiths Medical
- McKesson Corporation
- Medline Industries LP
- ICU Medical Inc.
- Abbott Laboratories
- Catalent Inc.
- Retractable Technologies Inc.
- Gerresheimer AG
- Schott AG
- EXELINT International Co.
- Connecticut Hypodermics Inc.
- Vygon Group
- Vita Needle Company
- Unilife Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Weigao Group (WEGO)
- Yangzhou Medline Industry Co. Ltd.
- Jiangsu Jichun Medical Devices Co. Ltd.
- Jiangsu Zhengkang Medical Apparatus Co. Ltd.
- Jiangyin Fanmei Medical Devices Co. Ltd.
- Shandong Zibo Shanchuan Medical Instrument Co. Ltd.
- Hi-Tech Medics Pvt. Ltd.
- DeRoyal Industries Inc.
- Argon Medical Devices Inc.
Frequently Asked Questions:
1] What segments are covered in the Global Hypodermic Needles Market report?
Ans. The segments covered in the Market report are based on Application, Type, and Procedural Volume.
2] Which region is expected to hold the highest share in the Global Market?
Ans. The North American region is expected to hold the highest share in Market.
3] What is the market size of the Global Market by 2032?
Ans. The market size of the Global Market by 2032 is expected to reach US$ 4.56 Bn.
4] What is the forecast period for the Global Market?
Ans. The forecast period for the Market is 2026-2032.
5] What was the market size of the Global Market in 2025?
Ans. The market size of the Global Market in 2025 was valued at US$ 2.94 Bn.